Lyra Therapeutics, Inc.LYRANASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank17
3Y CAGR-11.1%
5Y CAGR-43.8%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-11.1%/yr
Annual compound
5Y CAGR
-43.8%/yr
Recent acceleration
Percentile
P17
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 57.96 | -60.2% |
| 2023 | 145.76 | +148.0% |
| 2022 | 58.78 | -28.7% |
| 2021 | 82.50 | +26.2% |
| 2020 | 65.39 | -93.7% |
| 2019 | 1036.24 | +2008.0% |
| 2018 | -54.31 | - |